Skip to main content
. 2018 Jan 10;57(4):639–650. doi: 10.1093/rheumatology/kex484

Fig. 1.

Fig. 1

Correlation between rituximab serum levels at different time points and duration of B cell depletion

The duration of B-cell depletion was computed in each patient as the time between the date of the first rituximab infusion and the date of the first visit with B cells ≥10/µl. The correlation with serum levels of rituximab at the different visits was assessed by Spearman’s test.